phenylarsonous acid has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dick, LJ; Elliott, MA; Ford, SJ; Gray, A; Halbert, GW; Hogg, PJ; Hume, A; Parris, C; Ram, A | 1 |
| Camphausen, K; Chinen, L; Dilda, PJ; Don, AS; Dyszlewski, M; Hemenway, C; Hogg, PJ; Karwa, A; Kuan, KT; MacDonald, J; Massamiri, T; Naik, A; Park, D; Warner, B; Wong, JW | 1 |
2 other study(ies) available for phenylarsonous acid and Benign Neoplasms
| Article | Year |
|---|---|
Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing.
Topics: Anti-Infective Agents; Antineoplastic Agents; Arsenicals; Chelating Agents; Infusions, Parenteral; Neoplasms; Staphylococcus aureus; Sulfhydryl Compounds | 2013 |
Noninvasive imaging of cell death using an Hsp90 ligand.
Topics: Animals; Arsenicals; Carbocyanines; Carcinoma, Lewis Lung; Cell Death; Colorectal Neoplasms; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Pentetic Acid; Peptides; Protein Binding; Radioisotopes | 2011 |